Bestmade Natural Products Instant Calm With Lavender

Dosage for Clematis Vitalba Flower extracts must be highly individualized based on the patient's sensitivity and the specific clinical indication.

• Allergen Immunotherapy (Induction Phase): Treatment typically begins with a very low concentration (e.g., 0.01 mL of a 1:100,000 w/v dilution). Doses are increased weekly or bi-weekly by 0.05 mL to 0.1 mL until a maintenance dose is reached.
• Maintenance Phase: The maintenance dose is usually between 0.2 mL and 0.5 mL of a 1:100 or 1:20 w/v concentration, administered every 2 to 4 weeks.
• Diagnostic Testing: A single drop of a 1:20 w/v extract is typically used for skin prick testing. For intradermal testing, 0.02 mL of a 1:1000 dilution may be used.

Clematis Vitalba Flower extracts may be used in children, typically aged 5 years and older, who exhibit significant allergic symptoms that are not well-controlled by standard medications.

• Dosing Protocol: The pediatric dosing schedule follows the same gradual escalation (induction) as the adult protocol, but the final maintenance dose may be adjusted based on the child's weight and tolerance.
• Safety Note: Children under 5 years of age are generally not candidates for immunotherapy due to the difficulty in communicating symptoms of an impending systemic reaction.

Renal Impairment

Specific dose adjustments for renal impairment are not typically required for allergenic extracts, as the protein load is minimal. However, patients with severe renal disease should be monitored for fluid balance if adrenergic effects are anticipated.

Hepatic Impairment

No specific adjustments are required for patients with liver disease, as the metabolism of the extract is primarily proteolytic rather than hepatic.

Elderly Patients

Elderly patients (65+) require cautious dosing. The adrenergic agonist properties of Clematis Vitalba may place additional strain on the cardiovascular system. Healthcare providers may choose a slower induction phase to monitor for tachycardia (rapid heart rate) or hypertension (high blood pressure).

• Administration: Clinical extracts for immunotherapy MUST be administered by a healthcare professional in a facility equipped to treat anaphylaxis.
• Observation Period: Patients must remain in the clinic for at least 30 minutes following an injection to monitor for adverse reactions.
• Storage: Extracts should be stored in a refrigerator between 2°C and 8°C (36°F to 46°F). Do not freeze. Protect from light to prevent protein degradation.
• Consistency: For immunotherapy to be effective, doses must be taken on a regular schedule. If a dose is missed for an extended period, the dose may need to be 'stepped back' to a lower concentration to ensure safety.

If you miss a scheduled immunotherapy injection:

• Less than 1 week late: The usual dose is typically given.
• 1 to 2 weeks late: The dose may be held at the previous level rather than increased.
• More than 3 weeks late: The dose may need to be reduced significantly to avoid a systemic reaction upon re-exposure.

An overdose of Clematis Vitalba Flower extract (either through incorrect volume or incorrect concentration) is a medical emergency.

• Signs of Overdose: Rapid onset of hives, swelling of the throat, wheezing, drop in blood pressure, and rapid heart rate.
• Emergency Measures: Immediate administration of epinephrine (EpiPen), followed by antihistamines and corticosteroids. Seek emergency medical attention immediately if an overdose is suspected.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or frequency without medical guidance, as this significantly increases the risk of life-threatening reactions.

Most patients undergoing treatment with Clematis Vitalba Flower extracts will experience some form of local reaction. These are generally mild and expected as the body adjusts to the allergen.

• Injection Site Redness (Erythema): A red patch at the site of the injection, usually appearing within minutes.
• Local Swelling (Edema): A small 'wheal' or lump at the injection site. If the swelling is smaller than the size of a half-dollar (approx. 3 cm), it is considered a normal reaction.
• Itching (Pruritus): Localized itching around the injection area.
• Fatigue: Some patients report feeling unusually tired for a few hours following an immunotherapy session.

• Large Local Reactions: Swelling that exceeds 5-10 cm in diameter, which may last for 24 to 48 hours.
• Nasal Congestion: A temporary increase in 'stuffiness' or sneezing shortly after administration.
• Headache: Mild to moderate tension-type headaches.
• Tachycardia: A noticeable increase in heart rate, likely due to the adrenergic alpha/beta-agonist properties of the extract.

• Generalized Hives (Urticaria): Itchy bumps appearing on parts of the body away from the injection site.
• Angioedema: Deep tissue swelling, particularly around the eyes, lips, or tongue.
• Hypertension: A transient rise in blood pressure.
• Palpitations: The sensation of the heart skipping a beat or pounding in the chest.

> Warning: Stop taking Clematis Vitalba Flower and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.

• Difficulty Breathing: Wheezing, shortness of breath, or a feeling of 'tightness' in the chest.
• Throat Tightness: A sensation that the airway is closing or difficulty swallowing.
• Dizziness or Fainting: A sudden drop in blood pressure (hypotension) leading to lightheadedness or loss of consciousness.
• Cyanosis: A bluish tint to the lips or fingernails, indicating a lack of oxygen.
• Rapid, Weak Pulse: A sign of cardiovascular collapse during a severe systemic reaction.

With prolonged use (3-5 years of immunotherapy), the goal is permanent immune tolerance. However, long-term risks may include:

• Persistent Sensitization: In rare cases, a patient may become more sensitive to the allergen over time rather than less.
• Cardiovascular Strain: In patients with pre-existing heart conditions, the repeated adrenergic stimulation from certain extracts could theoretically contribute to worsening of underlying arrhythmias.

WARNING: RISK OF SEVERE ALLERGIC REACTIONS

Clematis Vitalba Flower extracts, like other allergenic extracts, can cause severe, life-threatening systemic allergic reactions, including anaphylaxis.

• Supervision: This medication must only be administered in a setting where emergency equipment and personnel trained in treating anaphylaxis are immediately available.
• Observation: Patients must be observed for at least 30 minutes after each injection.
• Pre-existing Conditions: Patients with unstable asthma or those taking beta-blockers may be at increased risk for severe reactions and may be less responsive to epinephrine treatment.

Report any unusual symptoms or side effects to your healthcare provider promptly. Keeping a log of local reactions can help your doctor adjust your dose safely.

Clematis Vitalba Flower is a potent biological substance. It is not a standard pharmaceutical drug but a complex extract that interacts directly with the immune and autonomic nervous systems. Patients must be aware that the primary risk is an overreaction of the immune system. This treatment is a long-term commitment, often requiring 3 to 5 years of consistent therapy to achieve lasting results.

No FDA black box warnings for Clematis Vitalba Flower. (Note: While many allergenic extracts carry class-wide warnings regarding anaphylaxis, specific branded products containing Clematis Vitalba may have varying labeling requirements. Always refer to the specific package insert provided by the manufacturer.)

• Anaphylaxis Risk: The most significant risk is a systemic allergic reaction. Patients should be educated on the early signs of anaphylaxis, such as itchy palms, a 'sense of impending doom,' or a metallic taste in the mouth.
• Asthma Stability: Patients with asthma must have their condition well-controlled before receiving an injection. If you are experiencing an asthma flare-up or your peak flow meter readings are low, your doctor may postpone your dose.
• Cardiovascular Disease: Because Clematis Vitalba has adrenergic alpha and beta-agonist properties, it can increase heart rate and blood pressure. Patients with a history of heart attack, unstable angina, or severe hypertension must be evaluated carefully.
• Autoimmune Disorders: Patients with active autoimmune diseases (e.g., lupus, rheumatoid arthritis) may experience a worsening of their condition as the extract stimulates the immune system.

To ensure safety, your healthcare provider will perform the following:

• Pre-Injection Assessment: Checking for current illness, fever, or asthma symptoms.
• Vital Signs: Monitoring blood pressure and heart rate before and after administration, especially during the induction phase.
• Peak Flow Testing: For asthmatic patients, a peak flow test may be required before each injection to ensure lung function is optimal.
• Skin Reaction Log: Documentation of the size and duration of local reactions to guide subsequent dosing.

Clematis Vitalba Flower does not typically cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine for a reaction, they should not drive or operate heavy machinery until they have fully recovered and been cleared by a physician.

Alcohol consumption should be avoided on the day of an immunotherapy injection. Alcohol causes vasodilation (widening of blood vessels), which can increase the speed at which the allergen is absorbed into the bloodstream, potentially increasing the risk of a systemic reaction.

Immunotherapy should not be stopped suddenly without consulting your doctor. While there is no 'withdrawal' syndrome, stopping treatment early will result in the return of allergic symptoms. If treatment must be discontinued due to severe side effects, your doctor will provide a plan for managing your allergies with alternative medications.

> Important: Discuss all your medical conditions, including any history of heart problems or respiratory issues, with your healthcare provider before starting Clematis Vitalba Flower.

• Non-Selective Beta-Blockers (e.g., Propranolol, Nadolol): These medications are contraindicated in patients receiving allergenic extracts. Beta-blockers can make an allergic reaction more severe and, crucially, they block the effects of epinephrine (adrenaline). If a patient on a beta-blocker has anaphylaxis, the standard life-saving treatment (epinephrine) may not work.

• Selective Beta-1 Blockers (e.g., Atenolol, Metoprolol): While less risky than non-selective versions, they still pose a significant risk during immunotherapy. Use requires a careful risk-benefit analysis by a specialist.
• MAO Inhibitors (e.g., Phenelzine, Selegiline): Because Clematis Vitalba has adrenergic agonist properties, combining it with MAOIs can lead to a dangerous increase in blood pressure (hypertensive crisis).
• Tricyclic Antidepressants (e.g., Amitriptyline): These can potentiate the effects of adrenergic agonists on the cardiovascular system, leading to arrhythmias or hypertension.

• Other Adrenergic Agonists (e.g., Pseudoephedrine, Albuterol): Using these alongside Clematis Vitalba may result in additive effects, such as increased jitteriness, insomnia, or rapid heart rate.
• Corticosteroids: While often used to treat allergic reactions, long-term high-dose steroid use can suppress the immune response, potentially making the immunotherapy less effective.

• High-Caffeine Intake: Caffeine is a stimulant that can exacerbate the adrenergic effects of the extract, leading to increased heart rate and anxiety.
• Alcohol: As mentioned, alcohol increases peripheral blood flow and can accelerate allergen absorption, increasing the risk of systemic reactions.

• St. John's Wort: May interact with the metabolic pathways of various compounds, though the clinical significance for allergenic extracts is low.
• Ephedra/Ma Huang: This herbal stimulant has potent adrenergic effects and should never be used with Clematis Vitalba Flower due to the risk of severe cardiovascular strain.
• Licorice Root: Can increase blood pressure and may potentiate the alpha-adrenergic effects of the extract.

• Skin Tests: Clematis Vitalba Flower will interfere with other allergy skin tests. If you are undergoing allergy testing for other substances, you must inform the technician that you are receiving Clematis immunotherapy.
• IgE Testing: Total and specific IgE levels may fluctuate during the course of treatment and may not accurately reflect clinical symptoms during the induction phase.

For each major interaction, the mechanism typically involves either pharmacodynamic synergy (both substances affecting the heart/lungs in the same way) or interference with emergency treatment (beta-blockers vs. epinephrine). Management usually involves switching to safer alternative medications before starting Clematis Vitalba Flower therapy.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure, heart rhythm, or depression.

Clematis Vitalba Flower must NEVER be used in the following circumstances:

• Severe, Unstable Asthma: Patients with an FEV1 (Forced Expiratory Volume) consistently below 70% of predicted values are at an unacceptably high risk for fatal bronchospasm during a reaction.
• Recent Myocardial Infarction (Heart Attack): Within the last 3-6 months. The adrenergic stress of the extract could trigger another cardiac event.
• Hypersensitivity to Excipients: Some extracts contain phenol or glycerin as preservatives; patients with known allergies to these must not use the extract.
• Beta-Blocker Therapy: Due to the inability to treat anaphylaxis effectively with epinephrine.

Conditions requiring careful risk-benefit analysis include:

• Pregnancy: While not strictly contraindicated if the patient is already on a maintenance dose, starting immunotherapy during pregnancy is generally avoided due to the risk of anaphylaxis-induced fetal hypoxia (lack of oxygen to the baby).
• Autoimmune Diseases: Such as Multiple Sclerosis or Crohn's disease, where immune stimulation might trigger a flare.
• Severe Hypertension: If blood pressure is not well-controlled, the adrenergic properties of the extract may cause dangerous spikes.

Patients allergic to Clematis Vitalba may also react to other members of the Ranunculaceae (Buttercup) family, such as Anemone or Ranunculus. If you have had a severe reaction to any of these plants, inform your allergist, as cross-reactivity is possible.

> Important: Your healthcare provider will evaluate your complete medical history, including your lung function and cardiovascular health, before prescribing Clematis Vitalba Flower.

Pregnancy Category C. There are no adequate and well-controlled studies of Clematis Vitalba Flower in pregnant women.

• Risk Assessment: The primary concern is not direct toxicity to the fetus, but the risk of maternal anaphylaxis. A severe allergic reaction can cause a sudden drop in maternal blood pressure, leading to decreased uterine blood flow and fetal distress or death.
• Clinical Practice: Most allergists will not start a new course of Clematis Vitalba immunotherapy during pregnancy. However, if a woman is already on a stable maintenance dose and is tolerating it well, the treatment may be continued at that same dose (without further increases).

It is not known whether the components of Clematis Vitalba Flower extract are excreted in human milk. Because the active components are large proteins that are likely digested in the infant's gastrointestinal tract, the risk to a nursing infant is considered low. However, breastfeeding mothers should be monitored for any unusual systemic reactions that could indirectly affect milk production or the ability to care for the infant.

• Approved Age: Generally used in children 5 years of age and older.
• Growth Effects: There is no evidence that allergenic extracts affect growth or development in children.
• Special Considerations: Children must be able to sit still for the 30-minute observation period and be able to describe symptoms like an 'itchy throat' or 'upset stomach,' which can be early signs of a reaction.

Patients over age 65 are at higher risk for adverse effects from the adrenergic properties of Clematis Vitalba.

• Cardiovascular Monitoring: Pre-existing arrhythmias or ischemic heart disease make this population more vulnerable to the beta-1 and alpha-1 effects of the extract.
• Polypharmacy: Older adults are more likely to be taking interacting medications like beta-blockers or diuretics, necessitating a thorough medication review.

No specific dose adjustments are required. However, patients with end-stage renal disease (ESRD) should be monitored for their ability to clear the metabolic byproducts of the protein extract, although this is rarely a clinical concern.

No adjustments are needed for patients with liver cirrhosis or hepatitis, as the liver does not play a primary role in the clearance of these allergenic proteins.

> Important: Special populations require individualized medical assessment. Always inform your specialist if you are pregnant, planning to become pregnant, or have underlying kidney or liver issues.

Clematis Vitalba Flower acts as a biological response modifier. Its primary action is the induction of immune tolerance. By introducing the allergen via the subcutaneous route, the extract bypasses the normal mucosal barriers. This promotes the development of Regulatory T-cells (Tregs), which secrete anti-inflammatory cytokines like IL-10 and TGF-beta. These cytokines suppress the Th2 allergic response and signal B-cells to switch production from IgE to IgG4.

Additionally, the Adrenergic alpha and beta-Agonist [MoA] involves the extract's constituents binding to adrenergic receptors. Alpha-1 binding triggers the Gq protein pathway, increasing intracellular calcium and causing smooth muscle contraction (vasoconstriction). Beta-2 binding triggers the Gs protein pathway, increasing cyclic AMP (cAMP) and causing smooth muscle relaxation in the bronchioles.

• Onset of Immunological Effect: Weeks to months (requires multiple doses to shift antibody production).
• Onset of Adrenergic Effect: 15–30 minutes post-administration.
• Duration of Effect: The immunological 'memory' can last for years after a 3-5 year course is completed.

| Parameter | Value |

|---|---|

| Bioavailability | Low (Subcutaneous/Local) |

| Protein Binding | High (to specific antibodies) |

| Half-life | Proteins: Hours; Immunological effect: Years |

| Tmax | 1–3 hours (for systemic absorption) |

| Metabolism | Proteolysis (Protease enzymes) |

| Excretion | Renal (Metabolites) |

• Molecular Components: Contains protoanemonin (a glycoside), saponins, and various allergenic proteins.
• Solubility: Aqueous extracts are soluble in water and saline.
• Description: A clear to slightly yellow liquid extract derived from the dried or fresh flowers of Clematis vitalba.

Clematis Vitalba Flower belongs to the Standardized and Non-Standardized Allergenic Extracts therapeutic class. It is related to other plant extracts like Ragweed, Timothy Grass, and Oak extracts used in immunotherapy.